0001609251-24-000004.txt : 20240520
0001609251-24-000004.hdr.sgml : 20240520
20240227131153
ACCESSION NUMBER: 0001609251-24-000004
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240227
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001177648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-87373
FILM NUMBER: 24684628
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 607 0800
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Krensavage Asset Management, LLC
CENTRAL INDEX KEY: 0001609251
ORGANIZATION NAME:
IRS NUMBER: 262520930
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 610 FIFTH AVENUE
STREET 2: SUITE 301
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 212-888-1582
MAIL ADDRESS:
STREET 1: 610 FIFTH AVENUE
STREET 2: SUITE 301
CITY: NEW YORK
STATE: NY
ZIP: 10020
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001609251
XXXXXXXX
LIVE
COMMON STOCK, Par Value $0.01 Per Share
02/22/2024
0001177648
ENANTA PHARMACEUTICALS INC
29251M106
500 ARSENAL STREET
WATERTOWN
MA
02472
Rule 13d-1(c)
Krensavage Asset Management, LLC
a
DE
0.00
1086024.00
0.00
1086024.00
1086024.00
5.1
IA
KRENSAVAGE PARTNERS LP
a
DE
0.00
979910.00
0.00
979910.00
979910.00
4.6
PN
Krensavage Partners Too, LP
a
DE
0.00
106114.00
0.00
106114.00
106114.00
0.5
PN
ENANTA PHARMACEUTICALS INC
500 ARSENAL STREET , WATERTOWN, MASSACHUSETTS, 02472
(i) Krensavage Partners, LP (KP) with respect to shares of Common Stock directly owned by it.
(ii) Krensavage Partners Too, LP (KPT) with respect to shares of Common Stock directly owned by it.
(iii) Krensavage Asset Management LLC (KAM) with respect to shares of Common Stock beneficially owned by it.
610 Fifth Avenue, Suite 301 New York, NY 10020
Delaware
N
IA
1,086,024
5.1%
0
1,086,024
0
1,086,024
Y
N
N
As the discretionary investment manager of the KP and KPT LP's, KAM has the power to direct the voting and disposition of shares held by KP and KPT LP's.
Y
N
See Item(s) 2(a), 2(b), 2(c), 2(d) of Ownership Group - Krensavage Partners, LP (KP) and Krensavage Partners Too, LP (KPT) and Krensavage Asset Management LLC (KAM)
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Krensavage Asset Management, LLC
/s/ Paul J. Paolino
Chief Financial Officer & Chief Compliance Officer
02/26/2024
KRENSAVAGE PARTNERS LP
/s/ Paul J. Paolino
Chief Financial Officer & Chief Compliance Officer
02/26/2024
Krensavage Partners Too, LP
/s/ Paul J. Paolino
Chief Financial Officer & Chief Compliance Officer
02/26/2024